[ON THE CLINICAL ADJUSTABILITY OF VARIOUS FORMS OF DIABETES IN DELAYED-ACTION INSULIN THERAPY, COMBINED AND EXCLUSIVELY ORAL THERAPY WITH SULFONYLUREA DERIVATIVES AND BIGUANIDES].
D001645:Biguanides; D003692:Delayed-Action Preparations; D003920:Diabetes Mellitus; D004358:Drug Therapy; D019791:Guanidine; D006146:Guanidines; D006801:Humans; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds
D001645:Biguanides; D003692:Delayed-Action Preparations; D006146:Guanidines; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D019791:Guanidine
ANTIDIABETICS; BIGUANIDES; DELAYED-ACTION PREPARATIONS; DIABETES MELLITUS; DRUG THERAPY; GUANIDINES; INSULIN
ZUR KLINISCHEN EINSTELLBARKEIT DER VERSCHIEDENEN DIABETESFORMEN UNTER VERZOEGERUNGSINSULIN, KOMBINIERTER UND ALLEINIGER ORALER THERAPIE MIT SULFONYLHARNSTOFF-DERIVATEN UND BIGUANIDEN.